Alpha Cubed Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Alpha Cubed Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8,735	Closed	-$317K	–	208
2016 Q4	$317K	Sell	8,735 -4,400	-33%	-$176K	0.08%	142
2016 Q3	$604K	Buy	+13,135	New	+$685K	0.16%	90
2016 Q2	–	Sell	-13,915	Closed	-$745K	–	166
2016 Q1	$745K	Sell	13,915 -3,450	-20%	-$202K	0.23%	74
2015 Q4	$1.14M	Sell	17,365 -450	-3%	-$27.8K	0.3%	70
2015 Q3	$1.05M	Sell	17,815 -954	-5%	-$61.9K	0.28%	77
2015 Q2	$1.11M	Buy	18,769 +2,253	+14%	+$139K	0.3%	84
2015 Q1	$1.03M	Sell	16,516 -7,235	-30%	-$421K	0.32%	78
2014 Q4	$1.37M	Sell	23,751 -1,900	-7%	-$106K	0.53%	57
2014 Q3	$1.38M	Sell	25,651 -1,199	-4%	-$63.5K	0.65%	53
2014 Q2	$1.41M	Sell	26,850 -350	-1%	-$17.9K	0.63%	57
2014 Q1	$1.44M	Sell	27,200 -24,850	-48%	-$1.15M	0.75%	45
2013 Q4	$2.09M	Buy	+52,050	New	+$2.05M	0.75%	45

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha Cubed Investments's TEVA Position: Q1 2017 in Review

Alpha Cubed Investments sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 8,735 shares — an estimated $317K sold.

Alpha Cubed Investments first reported a position in TEVA in Q4 2013 and held it in 12 quarters. The position peaked at $2.09M in Q4 2013. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

Alpha Cubed Investments reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Alpha Cubed Investments sold 8,735 Teva Pharmaceuticals shares in Q1 2017, an estimated $317K.
Alpha Cubed Investments first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 12 quarters.
Alpha Cubed Investments's Teva Pharmaceuticals position peaked at $2.09M in Q4 2013.
686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Alpha Cubed Investments's 13F filing for Q1 2017, filed 2 May 2017.